Mika Tirkkonen

2.0k total citations
18 papers, 1.4k citations indexed

About

Mika Tirkkonen is a scholar working on Genetics, Molecular Biology and Oncology. According to data from OpenAlex, Mika Tirkkonen has authored 18 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 8 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Mika Tirkkonen's work include Genomic variations and chromosomal abnormalities (10 papers), Cervical Cancer and HPV Research (4 papers) and Genital Health and Disease (4 papers). Mika Tirkkonen is often cited by papers focused on Genomic variations and chromosomal abnormalities (10 papers), Cervical Cancer and HPV Research (4 papers) and Genital Health and Disease (4 papers). Mika Tirkkonen collaborates with scholars based in Finland, United States and Sweden. Mika Tirkkonen's co-authors include Olli Kallioniemi, Ritva Karhu, Anne Kallioniemi, Jorma Isola, Minna Tanner, Minna M. Tanner, Colin C. Collins, Åke Borg, Håkan Olsson and David Kowbel and has published in prestigious journals such as Human Pathology, Genes Chromosomes and Cancer and Acta Obstetricia Et Gynecologica Scandinavica.

In The Last Decade

Mika Tirkkonen

18 papers receiving 1.4k citations

Peers

Mika Tirkkonen

GENET

ONCOL

PFM

Carsten Schwäenen Germany

W. F. Benedict United States

Charlotte Jin Sweden

Sari Pennanen Finland

Anke Schwendel Germany

M.H. Champème France

Tasnim Chagtai United Kingdom

Kerstin Heselmeyer Sweden

Anna‐Maria Björkqvist Finland

Hannaleena Eerola Finland

Carsten Schwäenen Germany

Mika Tirkkonen

663 ×0.8

347 ×0.4

GENET

362 ×0.7

377 ×0.9

ONCOL

420 ×1.6

PFM

Citations per year, relative to Mika Tirkkonen Mika Tirkkonen (= 1×) peers Carsten Schwäenen

Countries citing papers authored by Mika Tirkkonen

Since Specialization

Citations

This map shows the geographic impact of Mika Tirkkonen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mika Tirkkonen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mika Tirkkonen more than expected).

Fields of papers citing papers by Mika Tirkkonen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mika Tirkkonen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mika Tirkkonen. The network helps show where Mika Tirkkonen may publish in the future.

Co-authorship network of co-authors of Mika Tirkkonen

This figure shows the co-authorship network connecting the top 25 collaborators of Mika Tirkkonen. A scholar is included among the top collaborators of Mika Tirkkonen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mika Tirkkonen. Mika Tirkkonen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Kholová, Ivana, et al.. (2022). Cytohistological findings in HPV‐negative cases from HPV primary screening programme: quality assurance study. Apmis. 130(10). 599–604. 1 indexed citations

Kholová, Ivana, Mika Tirkkonen, Risto Vuento, et al.. (2019). HIGH‐RISK HPV testing as the primary screening method in an organized regional screening program for cervical cancer: the value of HPV16 and HPV18 genotyping?. Apmis. 127(11). 710–716. 8 indexed citations

Vuento, Risto, et al.. (2018). Implementation of HPV‐based cervical cancer screening in an organised regional screening programme: 3 years of experience. Cytopathology. 30(2). 150–156. 16 indexed citations

Kujala, Paula, Mika Tirkkonen, Risto Vuento, et al.. (2016). Human papillomavirus test with cytology triage in organized screening for cervical cancer. Acta Obstetricia Et Gynecologica Scandinavica. 95(11). 1220–1227. 13 indexed citations

Tolonen, Teemu, Jorma Isola, Antti Kaipia, et al.. (2015). Length of prostate biopsies is not necessarily compromised by pooling multiple cores in one paraffin block: an observational study. BMC Clinical Pathology. 15(1). 4–4. 3 indexed citations

Tolonen, Teemu, Paula Kujala, Marita Laurila, et al.. (2011). Routine dual-color immunostaining with a 3-antibody cocktail improves the detection of small cancers in prostate needle biopsies. Human Pathology. 42(11). 1635–1642. 6 indexed citations

Rennstam, Karin, Bo Baldetorp, Åke Borg, et al.. (2003). Patterns of chromosomal imbalances defines subgroups of breast cancer with distinct clinical features and prognosis. A study of 305 tumors by comparative genomic hybridization.. PubMed. 63(24). 8861–8. 122 indexed citations

Tirkkonen, Mika, Tommi Kainu, Niklas Loman, et al.. (1999). Somatic genetic alterations inBRCA2-associated and sporadic male breast cancer. Genes Chromosomes and Cancer. 24(1). 56–61. 49 indexed citations

Tirkkonen, Mika, Minna Tanner, Ritva Karhu, et al.. (1998). Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes and Cancer. 21(3). 177–184. 314 indexed citations

10.

Tirkkonen, Mika, Minna Tanner, Ritva Karhu, et al.. (1998). Molecular cytogenetics of primary breast cancer by CGH. Genes Chromosomes and Cancer. 21(3). 177–184. 21 indexed citations

11.

Bärlund, Maarit, Mika Tirkkonen, Farahnaz Forozan, et al.. (1997). Increased copy number at 17q22-q24 by CGH in breast cancer is due to high-level amplification of two separate regions. Genes Chromosomes and Cancer. 20(4). 372–376. 83 indexed citations

12.

Karhu, Ritva, et al.. (1997). Quality control of CGH: Impact of metaphase chromosomes and the dynamic range of hybridization. Cytometry. 28(3). 198–205. 59 indexed citations

13.

Tirkkonen, Mika, Oskar T. Johannsson, Bjarni A. Agnarsson, et al.. (1997). Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations.. PubMed. 57(7). 1222–7. 287 indexed citations

14.

Tirkkonen, Mika, Ritva Karhu, Olli Kallioniemi, & Jorma Isola. (1996). Evaluation of camera requirements for comparative genomic hybridization. Cytometry. 25(4). 394–398. 8 indexed citations

15.

Tanner, Minna M., Mika Tirkkonen, Anne Kallioniemi, et al.. (1996). Independent amplification and frequent co-amplification of three nonsyntenic regions on the long arm of chromosome 20 in human breast cancer.. PubMed. 56(15). 3441–5. 162 indexed citations

16.

Tanner, Minna M., Mika Tirkkonen, Anne Kallioniemi, et al.. (1995). Amplification of chromosomal region 20q13 in invasive breast cancer: prognostic implications.. PubMed. 1(12). 1455–61. 119 indexed citations

17.

Tanner, Martin A., Mika Tirkkonen, Trond Stokke, et al.. (1994). Amplification of 20q13 locus in breast cancer: -Defining the minimal region. Cancer Genetics and Cytogenetics. 77(2). 158–158. 2 indexed citations

18.

Tanner, Minna M., Mika Tirkkonen, Anne Kallioniemi, et al.. (1994). Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes.. PubMed. 54(16). 4257–60. 155 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact